Reprint

Current Updates on Interventional Cardiac Electrophysiology

Edited by
August 2023
210 pages
  • ISBN978-3-0365-8458-4 (Hardback)
  • ISBN978-3-0365-8459-1 (PDF)

This book is a reprint of the Special Issue Current Updates on Interventional Cardiac Electrophysiology that was published in

Medicine & Pharmacology
Public Health & Healthcare
Summary

Rapid developments have taken place over the recent years in the interventional cardiac electrophysiology. New methods and tools in the diagnosis and treatment of cardiac arrhythmia have emerged. There are many questions which still present a challenge, such as the ablation of refractory ventricular tachycardia, how to improve the long-term success rate of persistent atrial fibrillation, the long-term effectiveness and safety of His–Purkinje conduction system pacing. Accordingly, we dedicate this Special Issue Current Updates on Interventional Cardiac Electrophysiology to gathering the most recent progress in this field. Its aim is to present an overview of the current knowledge, latest evidence, and unresolved issues in this field. More specifically, the topics of interest include but are not limited to: atrial fibrillation; cryoablation; radiofrequency ablation; cardiac resynchronization therapy; His–Purkinje conduction system pacing; stereotactic radiotherapy for refractory ventricular tachycardia; pulsed electric field ablation; leadless pacemakers; and implantable cardioverter-defibrillators.

Format
  • Hardback
License
© 2022 by the authors; CC BY-NC-ND license
Keywords
atrial fibrillation; catheter ablation; left atrial appendage occlusion; stereotactic body radiotherapy; refractory ventricular tachycardia; treatment; ablation; atrial fibrillation; elderly patients; younger patients; outcomes; deep learning; convolution neural network; paroxysmal supraventricular tachycardia; electrocardiography; detection; syncope; vasovagal syncope; catheter ablation; ganglionated plexus; high-frequency stimulation; atrial fibrillation (AF); vein of Marshall (VOM); ethanol infusion; coronary sinus (CS); coronary sinus ostium (CSo); cardiac implantable electronic device infection; pocket infection; antimicrobial therapy; risk factors; preventive strategies; ventricular arrhythmias; catheter ablation; electrocardiogram; algorithm; left ventricular outflow tract; COVID-19 pandemic; atrial fibrillation; interventional therapy; catheter ablation; percutaneous left atrial appendage occlusion; pharmacotherapy; amiodarone; arrhythmogenic right ventricular cardiomyopathy; abnormal electrograms; ventricular tachycardia; ablation; iatrogenic atrial septal defect; intracardiac echocardiography; left atrial appendage closure; atrial fibrillation; right-to-left shunt; atrial fibrillation; vein of Marshall; ethanol infusion; collateral circulation; slow injection; paroxysmal atrial fibrillation; high-power; short-duration; radiofrequency ablation; ablation index; pulmonary vein reconnection; non-pulmonary vein triggers; atrial fibrillation; vein of Marshall; left atrial appendage occlusion; peri-device leak; cardiac computed tomography angiography; leadless single-chamber pacemaker; complication; atrioventricular synchrony; leadless dual-chamber pacemaker; strategy selection